Beta-Blocker Use After Acute Myocardial Infarction
Background Beta-blocker (BB) benefits after acute myocardial infarction (AMI) may differ by heart failure (HF) phenotype in the contemporary reperfusion era. Objectives The authors evaluated associations of in-hospital BB therapy with 1-year outcomes after AMI complicated by HF, stratified by left ventricular ejection...